|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.735 USD | -0.18% |
|
-1.79% | +7.04% |
| 07-08 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Amid Tariff Pause | MT |
| 07-08 | ImmunityBio Granted UK Approval for Bladder Cancer Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNITYBIO, INC. | Bio Therapeutic Drugs | -0.36% | -1.79% | +7.04% | -57.19% | - | 2.42B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IBRX Stock
- Charts ImmunityBio, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition